- FoI Number
- 2024-442
- Subject
- Myasthenia Gravis
- Date Received
- 25/10/2024
- Request and Response
-
- The number of patients with generalised Myasthenia Gravis (gMG) treated in each month for July, August, and September 2024
Zero
- The volume of medication dispensed and/or consumed in each month for July, August, and September 2024 for each of the products below for gMG patients. If it is more convenient to specify the number of vials, pre-filled syringes, or tablets, that would also be very helpful.
- Steroids
- Acetylcholinerase Inhibitors (ACHEis)
- Immunosuppressants
- Anti-CD20 - Rituximab
- Immunoglobulins
- Anti-FcRn
- Complement Inhibitors
N/A
